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aggressive therapies such as complex devices or ultrafiltration, as well as enabling 
an enriched end of life experience for those beyond such therapies. Enabling end 
stage patients to die in their location of choice would also release considerable 
resources at the same time.
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Objectives: We wanted to compare the patient satisfaction and compliance 
between a hospital with a trained clinical psychologist, acting as a mediator 
between physicians and patients and a hospital without one. MethOds: The 
comparison was done between two identical cardiac hospitals, which belong 
to the same network of cardiac facilities, for a period of six months. At each 
hospital, 200 patients were included. The patient characteristics, numbers and 
patient flow were comparable; the facilities were identical as level of comfort 
and staff training. To measure the patient satisfaction we used a questionnaire. 
The level of attendance of control visits after discharge we measured with the 
hospital registry. How many of the 200 patients stick to the discharge therapy 
after 3 and after 6 months after discharge, we measured with the out-patient cen-
tre registry and by telephone interviews. Results: In each hospital 200 patients 
were included and followed-up. For the hospital without clinical psychologist, 
patient satisfaction was 79% excellent marks (n= 158), control visits attendance 
was 42% (n= 84), patient compliance was 72% (n= 144) on the 3rd and 65% (n= 130) 
on the 6th month after discharge. For the hospital with a clinical psychologist, 
patient satisfaction was 97% excellent marks (n= 194), control visits attendance 
was 78% (n= 156), patient compliance was 96% (n= 192) on the 3rd and 89% (n= 178) 
on the 6th month after discharge. With the help of a trained clinical psychologist, 
we witnessed the following differences: 18% improvement in patient satisfac-
tion, 36% better attendance to control visits, 24% more compliant patients for 
both the 3rd and 6th month after discharge. cOnclusiOns: Trained clinical 
psychologists may play the role of a mediator and close the communication gap 
between physicians and patients and lead to improved patient satisfaction and 
compliance.
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Objectives: We wanted to establish the gap between physicians’ and patients’ 
understanding of patient needs in a hospital setting. MethOds: The study was 
run in the four of the Bulgarian Cardiac Institute clinics. We used questionnaires 
and within a period of two months, first we asked 30 physicians and 50 patients 
about what patient needs are according to their understanding. Based on the 
answers we defined 10 categories for each of the two groups. Then we asked 143 
physicians and 500 patients to define which category is most and least important 
for them by using the Maximum Difference Scaling technique. Results: Courtesy, 
after discharge recommendations and information about the discharge drugs were 
the top three most important patient needs according to the patients. Life-saving 
activities, improvement of quality of life and improve the longevity were the top 
three most important patient needs according to the physicians. cOnclusiOns: 
There is a tremendous gap between patients’ and physicians’ perceptions of 
patient needs. It is very hard for the hospitals to increase patient satisfaction 
relying on medical services only. Further research is needed to find ways to close 
that gap.
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Objectives: Given ethnic variation in attitudes toward hypertension (Ford 2010; 
Lewis 2010), study objectives are to determine 1) patient preferences concerning med-
ication use as revealed by responses to Beliefs about Medicines Questionnaire (BMQ, 
Horne 1999) in an urban black population with hypertension (HTN) and 2) if these 
preferences were influenced by experiences with parents/friends HTN diagnoses.  
MethOds: After approval from Northeastern University’s Institutional Review 
Board, coded clinic appointment schedules were used to identify patients sched-
uled for routine HTN follow-up appointment at a Boston inner-city community 
health center. Researchers screened for eligibility (English speaking, black eth-
nicity, taking anti-hypertensive medication), described the study, and requested 
informed consent. Patients agreeing to participate and completing background 
questions and the hypertension-specific Beliefs about Medicines questionnaire 
(BMQ: 18 items, 5 levels, strongly agree-strongly disagree) received a $10 CVS-
provided gift card. Results: 189 patients were approached. 94 (49.7%) completed 
the questionnaire, 11.6% declined, and 38.6% didn’t meet criteria, e.g., didn’t speak 
English or had previously completed the BMQ. Patients averaged 55.6yo, 67% 
female. Overall BMQ factor scores were: Specific Necessity (SN), 3.41 ±0.83; Specific 
Concerns (SC), 2.82 ±0.8; General Overuse (GO), 2.98 ±0.74 and General Harm (GH), 
2.54 ±0.72. Patients whose parent had a stroke had higher SN (p= 0.038) and lower 
GH scores (p= 0.042) than patients without that prior experience. There was no dif-
ference in any factors as to whether parents or a friend did/didn’t have hyperten-
sion and whether a friend did/didn’t have a stroke. SC were lower in patients with 
higher educational level (p= 0.002). No statistical associations occurred between 
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Objectives: While the independent influence of metabolic and cardiovascular 
diseases on either quality of life (QoL) or survival is well studied, the evidence on 
the combined burden in terms of quality adjusted life years (QALYs) is rather weak. 
Previous burden of disease studies mostly combined cross-sectional QoL data 
with mortality statistics from other data sources. However, due to strong model 
assumptions these studies might be limited in validity and accuracy. The goal of 
this study was to analyze the intermediate burden of diabetes in patients with 
previous myocardial infarction in terms of QALYs lost, by introducing a method 
capable to exploit primary longitudinal data sources of population-based stud-
ies. MethOds: Data for this analysis were taken from the KORA-Acute Myocardial 
Infarction (AMI) Registry. QoL (Euro-Qol-5D-index, German tariff) of a subset of 
patients known to be alive was assessed through postal surveys in 2006 (n= 1022) 
and subsequently in 2011 (n= 716). Mortality was tracked by the routine surveil-
lance system of the AMI Registry. QALYs gained were calculated assuming a 
linear QoL change from baseline to follow-up. QoL trajectories of non-respond-
ers at follow-up and patients who died before follow-up were approximated by 
multiple imputation methods using the baseline QoL and covariate structure. 
Ordinary least square regression models were performed to quantify the QALYs 
and life years (LYs) lost over the mean observation time. Results: Over a mean 
observation time of 4 years, patients with diabetes lost 0.14 LYs (3.75 vs. 3.89, 
p< 0.01) and 0.36 QALYs (2.96 vs. 3.33, p< 0.01) more than patients without diabe-
tes. The QALY-gap was greatest for diabetic patients taking insulin (-0.66, p< 0.01). 
Sensitivity analyses showed that models were robust concerning model assump-
tions. cOnclusiOns: The intermediate burden of diabetes for patients with CVD 
is substantial. Using individual-level data from population-based follow-up of 
studies is a valuable methodological extension to accurately quantify the burden 
of chronic conditions.
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Objectives: A secondary analysis was carried out to test if differences existed in 
reported treatment satisfaction between non-valvular atrial fibrillation patients 
(NVAF) treated with vitamin K antagonist (VKA) anticoagulants and new oral anti-
coagulants (NOAC). MethOds: A sample of 1318 patients was recruited at random 
in the FANTASIIA study, between June 2013 and March 2014, from which 77% were 
using VKA and 23% NOAC at least 6 months before inclusion. The specific treatment 
satisfaction instrument SAFUCA was used to test differences between groups. The 
SAFUCA questionnaire is composed by 7 dimensions and overall score, measured 
in a 0 (least satisfied), 100 (most satisfied) scale. Guyatt’s d was used to estimate 
effect size. Results: Mean age was 73.8 (SD= 9.4) years, and 42.5% were women. 
Patients using NOACs attained statistically significant higher values in the overall 
score and in all SAFUCA dimensions. Overall score effect size (NOAC vs VKA) was 
medium-small (79.91 vs 73.22, d= 0.43, p< 0.001). Small to large effect sizes were 
also found by dimension: Effectiveness (77.63 vs 72.70, d= 0.33, p< 0.01), Ease and 
Convenience (80.99 vs 73.72, d= 0.49, p< 0.001), INR Controls (62.35 vs 57.66, d= 0.32, 
p< 0.01), Impact on Daily Activities (90.08 vs 81.97, d= 0.55, p< 0.001), Medication 
Undesired Effects (86.20 vs 79.21, d= 0.47, p< 0.001), Satisfaction with Medical Care 
(80.30 vs 69.38, d= 0.74, p< 0.001), and Overall Satisfaction (80.30 vs 69.38, d= 0.74, 
p< 0.001). cOnclusiOns: SAFUCA questionnaire was able to detect satisfaction 
differences between NVAF patients treated with NOAC and those treated with VKA, 
presenting medium effect size in most dimensions. This new evidences offer addi-
tional support to the questionnaire validity.
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Objectives: Unplanned patient admissions to hospital with heart failure (HF) are 
on the increase due to an ageing population and increasing survival post coronary 
disease. Pre-discharge mortality is high, predictable and often occurs after many 
days stay for many patients and often without palliative care involvement, not 
aligned with guidance. MethOds: We audited palliative care input to HF patients 
admitted to our hospital as the predominant condition and subsequently passing 
away, both before and after an awareness campaign, publishing barriers to end 
of life dialogues between patient and clinicians, demonstrating the early use of 
a Get With The Guidelines (GWTG) risk assessment tool to predict mortality and 
introduction of a daily HF nursing team service. Results: In 2009, amongst 57 HF 
patients the average time to death was 17.8 days, only 7% received any palliative 
input before death. The time to death in these patients correlated positively with the 
(GWTG) predictive score indicating that these deaths could have been anticipated 
and appropriate palliative involvement triggered. Data from 2010 to 2013 following 
these interventions (n= 99) showed a marked improvement with 44% of patients 
having palliative input before death. The average time to death in this group was 
comparable at 17.22 days. cOnclusiOns: The care of HF patients and their families 
can be greatly improved with early mortality prediction, sensitive dialogues, routine 
involvement of HF teams both to enhance survival for patients who will benefit from 
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Objectives: Since the introduction of non-vitamin-K-antagonist oral anticoagu-
lants (OACs), an additional option for stroke prevention in patients with atrial fibril-
lation (AF) compared to vitamin-K-antagonists (VKAs) is available. The objective 
of this study was to assess patients’ preferences regarding the attributes of these 
different treatment options. MethOds: We conducted a multicenter study among 
randomly selected physicians who were asked to recruit AF patients. Patients’ 
preferences were assessed by computer-assisted telephone interviews. We used a 
Discrete-Choice-Experiment (DCE) with four treatment dependent attributes (need 
of bridging: yes/no, interactions with food/nutrition: yes/no, need of INR controls/
dose adjustment: yes/no, frequency of intake: once/twice daily) and one compara-
tor attribute (distance to practitioner: < 1km/> 15km). Preferences measured in the 
interviews were analyzed descriptively and based on a conditional logistic regres-
sion model. Results: A total of 140 AF patients (age: 74.0±8.5 years; 57.0% male; 
mean CHA2DS2-VASc: 6.1±1.1; current medication: 27.1% rivaroxaban, 71.4% VKA, 
1.4% other) could be interviewed. Regardless of type of medication, patients signifi-
cantly preferred the attributes’ level (in order of patients’ importance) “once daily” 
for “frequency of intake” (binary-coded: once = 1 vs. twice = 0; Coefficient = 0.954; 
p< 0.001), “no” for “interaction with food/nutrition” (yes vs. no; -0.842; p< 0.001), “no” 
for “bridging necessary” (yes vs. no; -0.656; p< 0.001) and “≤ 1 km” for “distance to 
practitioner” (≤ 1 km vs. > 15 km; 0.644; p< 0.001). However, for the attribute “need of 
INR controls/dose adjustment” (yes vs. no; 0.020; p= 0.808) no significant preference 
in favour of one of the options are shown. cOnclusiOns: In our analyses, “once 
daily frequency of intake” was the most important attribute for patients’ choice 
followed by “no interactions with food/nutrition” and “no bridging necessary”. Thus, 
patients with AF seem to prefer treatment options which are easier to administer.
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Objectives: There are few studies in Spain about outcomes at 1-year in terms of 
health-related quality of life (HRQoL) in patients hospitalized by heart failure (HF). 
The main objective of the present study was to evaluate changes in HRQoL from 
baseline to 1-year post discharge in patients with HF through two questionnaires, 
SF-12 and Minnesota Living with Heart Failure questionnaire (MLHFQ). MethOds: 
This has been a prospective study with 502 patients admitted by HF in Basque 
Country (Spain). Patients completed questionnaires during their hospitalization and 
at 1-year. The MLHFQ is a specific instrument which has 21 items with an overall 
scale, physical (8 items) and emotional (5 items) subscales. MlhFQ items are scoring 
from 0 (best) to 5 (worst). Total score ranges from 0 to 105, physical domain from 
0 to 40 and emotional from 0 to 25. SF-12 has two dimensions, Physical Summary 
Score (PCS) and Mental Summary Score (MSC) which scores range from 0 (worst) 
to 100 (best). We have used general linear model to study gains in each dimension 
adjusted by baseline score, age, gender and hospital readmissions in the previous 
6 months. Results: Mean age was 76.7 (SD= 10.4), there were a 56.1% of men and 
20.3% of readmissions in the previous six months. Regarding both questionnaires 
and dimensions, baseline status influence in gains, the worse the baseline the more 
the gains. Likewise men have greater gains and patients readmitted lower in all 
domains. Age has an influence in MLHFQ physical domain and PCS. cOnclusiOns: 
Adjusted by baseline score and readmissions, men have greater improvements in 
all domains of MLHFQ and SF-12. On the other hand, the younger the patients the 
higher the improvement is, in physical domains however age does not have any 
influence in psychological domains.
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Objectives: To identify and summarize the key characteristics, strengths, and 
weaknesses of available patient-reported outcome (PRO) measures assessing treat-
ment satisfaction and health-related quality of life (HRQOL) related to anticoagula-
tion therapy in patients with atrial fibrillation, including evaluating how well the 
measures meet current regulatory guidance requirements in Europe and the United 
States. MethOds: Publications describing the development, validation, or use of 
PRO instruments in patients using anticoagulant therapy were identified through 
a comprehensive literature review. Several sources (PubMed, Patient-Reported 
Outcome and Quality of Life Instruments Database [PROQOLID], and ClinicalTrials. 
org) were reviewed to identify instruments. The development process and meas-
urement properties (internal consistency and test-retest reliability, convergent and 
divergent construct validity, known-groups validity, and responsiveness) of the iden-
tified instruments were compared. Results: Five measures assessing anticoagu-
self-reported adherence results and any of the 4 factor scores. cOnclusiOns: 
This study provides BMQ factor scores for urban black HTN patients and insight 
into how experiences of patient’s parents can be used to target increased per-
ception of anti-hypertensive medication necessity and reduce patient-specific 
medication harm concerns.
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Objectives: To investigate the living and employment situation of patients after 
stroke, and examine whether this differs by degree of disability. MethOds: We 
conducted an observational retrospective study among 569 post-stroke patients 
and examined changes in employment and living situation. The investigational 
period was divided into 3 intervals: < 3,3-6 and > 6 months after stroke. All patients 
had their mRS (modified Rankin Score, ranging from 0 full health to 5 severely 
dependent) measured at 3 months after stroke, plus an additional mRS assessment 
if their stroke was more than 6 months ago. Patients were recruited in 10 regional 
and university hospitals across Belgium using a convenience sample stratified by 
mRS. Results: Before their stroke the majority of patients lived at home (99%) 
despite the fact that 13% had a previous stroke. At 3 months after stroke an associa-
tion was found between the time spent in an inpatient care facility (hospital, reha-
bilitation facility, nursing home) and the mRS (p< 0.0001 Weibull survival analysis, 
average inpatients days were 9.2, 14.1, 27.7, 53.4, 67.0 and 73.4 for mRS 0-5 respec-
tively). Between 3 and 6 months after stroke on average 7% of patients were staying 
in a rehabilitation facility and 5% in a nursing home; these were mostly patients 
with mRS > = 3. After six months all patients returned home, except patients with 
mRS4 (36% home) and mRS5 (38% home). Before stroke 70% of patients were retired; 
in those working before their stroke, 16-20% patients in mRS categories 0-2 were 
working again compared to none in mRS category 3-5, of which 14% took early 
retirement or leave of absence. cOnclusiOns: Experiencing a mild stroke will 
not affect the patient’s employment and living situation beyond the short term; 
however suffering a severe stroke is likely to lead to significant changes in place of 
residence and occupation.
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Objectives: Evaluate validity and reliability of the UISESS-B oral health ques-
tionnaire in a Mexican diabetic, systemic hypertension and obese patients in the 
primary health care level. MethOds: Were studied 105 subjects with diabetes, 
systemic hypertension and/or over-weigh-obesity in the context of a diabetic’s 
control group in the Instituto Mexicano del Seguro Social. Was applied an oral 
health questionnaire named UISESS-B previously validated. The instrument is 
divided in three main areas: oral health care habits, oral health and nutrition 
related habits, and oral health care related symptoms and signs. ResultsConstruct 
validity was confirmed by the correct compilation of the items included in the 
two main constructs: habits and perceptions each one including specific multi-
item questionnaires (correlation coefficients ranged from 0.30 to 0.80, P>0.001); 
the reliability was confirmed by the internal consistency (Cronbach alpha: 0.55 
for the construct habits and 0.71 for the construct perceptions). cOnclusiOns: 
The UISESS-B questionnaire shows significant validity and reliability, suggesting 
its use as an instrument useful to be used as a patient reported outcome in oral 
health in patients with chronic diseases.
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Objectives: Many years ago, cardiologists developed on the basis of the 
Framingham study an “arterial age” which is very useful to sensitize patients to their 
cardiovascular risk. The purpose of the study was to develop a “venous age” to make 
people more aware of their venous disease and to better adhere to lifestyle improve-
ment and venous disease treatments. MethOds: The score calculation was based 
on an international epidemiological study conducted in 24 countries in the daily 
practice or general practitioners. The data base included patients with or without 
venous disease, whatever the reason for which they were consulting and whatever 
the level of their venous disease which was systematically described according the 
elements of the international CEAP classification. Results: The study covers 124 
235 patients aged of 52 among whom 69.4% were female. Among them 18.8% had no 
sign of venous disease (C0), 22.9% had only functional symptoms (C0s), 40.6% had 
Telangiectasies or reticular veins, 34.8% varicose, 24.9% edema, 14.0% skin changes, 
7.3 Healed ulcers and 4.3% active ulcers. The statistical analysis has determined 
the number of years which must be added to the real age to get the “venous age” 
by comparison of the age of somebody who has no venous functional symptoms 
or physical signs. The results provide that number for women and men according 
the different venous symptoms and sign they present. cOnclusiOns: This first 
attempt of creating a “venous age” will be certainly improved in the next future, 
using more complex analysis based on risk factors or other criteria, but it seems 
already efficient to make people aware of their venous risk and to better adhere to 
lifestyle improvement and venous disease treatments.
